Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: The role of morphology and immunohistochemistry

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 4, 2007, Pages 599-603

  Owens, Christopher L ^a   Epstein, Jonathan I ^a   Netto, George J ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CYTOKERATIN 20; EOSIN; HEMATOXYLIN; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONSULTATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; MALE; MEDICAL RECORD; MORPHOLOGY; OLIVARY NUCLEUS; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; SAMPLING; SENSITIVITY ANALYSIS; TISSUE NECROSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 34147105964     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Murray SK, Breau RH, Guha AK, Gupta R. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma. Am J Surg Pathol. 2004;28:1154-1162.
3. Bowrey DJ, Otter MI, Billings PJ. Rectal infiltration by prostatic adenocarcinoma: report on six patients and review of the literature. Ann R Coll Surg Engl. 2003;85:382-385.
4. Bailey CM, Gilbert JM. Avoiding inappropriate surgery for secondary rectal cancer. Eur J Surg Oncol. 2002;28:220-224.
5. Gupta T, Laskar SG, Thakur M, et al. Isolated prostatic metastasis from primary sigmoid colon carcinoma. Indian J Gastroenterol. 2004;23:114-115.
6. Mai KT, Landry DC, Collins JP. Secondary colonic adenocarcinoma of the prostate histologically mimicking prostatic ductal adenocarcinoma. Tumori. 2002;88:341-344.
7. Kumar R. Commentary: targeting colorectal cancer through molecular biology. Semin Oncol. 2005;32:S37-S39.
8. Dennis JL, Hvidsten TR, Wit EC, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766-3772.
9. Netto GJ. Tumors of unknown primary origin: the role of immunohistochemistry and molecular diagnostics. In: Perry MC, ed. American Society of Clinical Oncology 2002 Educational Book. Baltimore, Md: Lippincott Williams & Wilkins; 2002:343-347.
10. Bismar TA, Humphrey PA, Grignon DJ, Wang HL. Expression of beta-catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas. Am J Clin Pathol. 2004;121:557-563.
11. Magi-Galluzzi C, Luo J, Isaacs WB, Hicks JL, de Marzo AM, Epstein JI. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol. 2003;27:1128-1133.
12. Moskaluk CA, Zhang H, Powell SM, Cerilli LA, Hampton GM, Frierson HF Jr. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. 2003;16:913-919.
13. Stein BS, Vangore S, Petersen RO. Immunoperoxidase localization of prostatic antigens: comparison of primary and metastatic sites. Urology. 1984;24:146-152.
14. Hameed O, Humphrey PA. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol. 2005;22:88-104.
15. Fan CY, Wang J, Barnes EL. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol. 2000;24:579-586.
16. Black MH, Magklara A, Obiezu C, et al. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. Br J Cancer. 2000;82:361-367.
17. Elgamal AA, Ectors NL, Sunardhi-Widyaputra S, Van Poppel HP, Van Damme BJ, Baert LV. Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation. J Urol. 1996;156:464-468.
18. Alanen KA, Kuopio T, Koskinen PJ, Nevalainen TJ. Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues. Pathol Res Pract. 1996;192:233-237.
19. Xu J, Kalos M, Stolk JA, et al. Identification and characterization of prostein, a novel prostate-specific protein. Cancer Res. 2001;61:1563-1568.
20. Kalos M, Askaa J, Hylander BL, et al. Prostein expression is highly restricted to normal and malignant prostate tissues. Prostate. 2004;60:246-256.
21. Shevchuk MM, Romas NA, Ng PY, Tannenbaum M, Olsson CA. Acid phosphatase localization in prostate carcinoma: a comparison of monoclonal antibody to heteroantisera. Cancer. 1983;52:1642-1646.
22. Hameed O, Sublett J, Humphrey PA. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues. Am J Surg Pathol. 2005;29:579-587.
23. Schowinsky JT, Epstein JI. Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer. Am J Surg Pathol. 2006;30:866-870.
24. Helpap B, Kollermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch. 1999;434:385-391.